Presentation is loading. Please wait.

Presentation is loading. Please wait.

by Michael R. DeBaun, and Ellen Wright Clayton

Similar presentations


Presentation on theme: "by Michael R. DeBaun, and Ellen Wright Clayton"— Presentation transcript:

1 by Michael R. DeBaun, and Ellen Wright Clayton
Primum non nocere: the case against transplant for children with sickle cell anemia without progressive end-organ disease by Michael R. DeBaun, and Ellen Wright Clayton BloodAdv Volume 1(26): December 12, 2017 © 2017 by The American Society of Hematology

2 Estimated childhood for survival for children with SCA based on therapy.
Estimated childhood for survival for children with SCA based on therapy. Hypothetical cohort of 1000 children with SCA followed for 15 years receiving either HU therapy (children with severe disease) or HSCT. Mortality rates are based on the Belgium cohort study.10 Michael R. DeBaun, and Ellen Wright Clayton Blood Adv 2017;1: © 2017 by The American Society of Hematology


Download ppt "by Michael R. DeBaun, and Ellen Wright Clayton"

Similar presentations


Ads by Google